J&J Starts Two-dose Trial Of Its COVID-19 Vaccine Candidate

Johnson & Johnson launched a new largescale latestage trial on Monday to test a twodose regimen of its experimental COVID19 vaccine and evaluate potential incremental benefits for the duration of protection with a second dose.

from Top Business News- News18.com https://ift.tt/2IEIT7k